Hope for the Holidays
Regenerative Solutions Giving Animals the Comfort They Deserve
Regenerative Tools Designed for Better Joint Care
As you explore your Hope for the Holidays package, use this page as your hub for regenerative tools, CE opportunities, clinical success stories, and limited-time offers.
Build Your Multimodal Toolkit Today
Buy 4 Get 1 Free OR Buy 12 Get 4 Free through 12/31/25
Spryng® with OsteoCushion® Technology
Spryng is a naturally derived intra-articular injectable medical device made from collagen and elastin. It works to enhance joint cushioning and synovial fluid viscosity, and promote constructive tissue remodeling - making it an ideal solution for supporting joint recovery following orthopedic surgeries such as cruciate ligament or luxating patella procedures, or providing prophylactic support for the opposite limb during recovery.
PrecisePRP is a shelf-stable, leucoreduced platelet-rich plasma that eliminates the need for centrifugation while delivering consistent, reliable dosing. It integrates easily into your surgical protocols - supporting tissue regeneration, reducing inflammation, and accelerating recovery in tendon, ligament, and joint procedures.
Available for equine and canine species.
PrecisePRP™ - The only FDA-reviewed PRP on the market
Video & Educational Resources
What is PrecisePRP?
Dr. Kirsty Husby, Senior Technical Veterinarian at PetVivo Animal Health, outlines how PrecisePRP’s ready-to-use, centrifuge-free PRP is elevating regenerative care through consistency, convenience, and reliable clinical integration.
Real-World Results with Spryng: Dr. Julia Tomlinson on Restoring Mobility in Canine Patients
Dr. Julia Tomlinson, BVSc, MS, PhD, DACVS, DACVSMR, CCRP, CVSMT, shares how Spryng enhances her multimodal canine mobility and joint-health protocols.
How Spryng Stands Apart: Dr. Husby Explains Its Unique Approach to Osteoarthritis Treatment
Dr. Kirsty Husby, Senior Technical Veterinarian at PetVivo Animal Health, breaks down how Spryng differs from other common osteoarthritis (OA) treatments in both its science and mechanism of action.
Why Dr. Julia Tomlinson Uses PrecisePRP
Hear Dr. Julia Tomlinson, BVSc, MS, PhD, DACVS, DACVSMR, CCRP, CVSMT, share how she uses PrecisePRP to streamline workflow, ensure consistent dosing, and support better outcomes for dogs recovering from injury or managing chronic joint issues.
Success Stories
Free CE Courses & Clinical Learning
Continue your team’s OA education with evidence-based material from leading veterinary experts.
Advancing Care for Osteoarthritis in Small Animal Practice (Introductory)
Earn 1.0 CE Credit
Osteoarthritis (OA) is a debilitating condition that often leads to a progressively worsening quality of life for our patients, but recent research has helped us better understand the degenerative process leading to OA, allowing for the development of newer treatment techniques and novel therapies for OA management. In this program, we explore the latest treatment options and get tips on how to incorporate joint injections into a multimodal approach to OA management.
Opening the OA Toolbox: Diving Deeper into Joint Injections (Advanced)
Earn 1.0 CE Credit
This program covers an overview of Osteoarthritis (OA), including joint instability leading to arthritic changes. OA treatment modalities currently being implemented in general practice are discussed. Products available for intra-articular joint injections are reviewed, and detailed descriptions of how to perform joint injections are provided. Utilization of joint injections as proactive vs. reactive treatment is discussed.
Regenerative Therapies in Equine Practice: Optimizing Outcomes in OA Management
Earn 1.0 CE Credit
Osteoarthritis (OA) is a leading cause of lameness and performance decline in equine athletes across disciplines. Regenerative therapies have emerged as a valuable addition to the equine practitioners toolkit, offering new opportunities for tissue repair, inflammation control, and disease modification. This program provides a comprehensive review of equine OA pathophysiology and discusses key drivers of degenerative joint disease in equine athletes. The latest advancements in regenerative modalities, including platelet rich plasma (PRP), stem cells, Spryng, and combination strategies, will be discussed in detail along with a literature review and supportive evidence for their use. Attendees will learn how to identify suitable candidates for regenerative therapy, design treatment plans, and incorporate regenerative options as part of a multimodal proactive approach to joint care.